Planta Med 2001; 67(9): 787-790
DOI: 10.1055/s-2001-18843
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Differential Activation by Daphnetoxin and Mezerein of PKC-Isotypes α, βI, δ and ζ

Lucília Saraiva1 , Paula Fresco1 , Eugénia Pinto2 , Helena Portugal3 , Jorge Gonçalves1
  • 1 Department of Pharmacology, CEQOFFUP, Faculty of Pharmacy, University of Porto, Porto, Portugal
  • 2 Department of Microbiology, CEQOFFUP, Faculty of Pharmacy, University of Porto, Porto, Portugal
  • 3 Chemistry Section, University of Trás-os-Montes e Alto Douro, Vila Real, Portugal
Further Information

Publication History

December 19, 2000

March 4, 2001

Publication Date:
06 December 2001 (online)

Zoom Image

Abstract

Daphnetoxin, a mezerein derivative, was isolated from the stem bark of Daphne gnidium. Mezerein is a PKC activator that exhibits antileukemic properties. However, daphnetoxin and its analogue 12-hydroxydaphnetoxin were described as being devoid of this effect. In the present study daphnetoxin and mezerein were compared as PKC activators on classical (α and βI), novel (δ) and atypical (ζ) isoforms, using an alternative in vivo yeast phenotypic assay. The aim was to clarify if daphnetoxin is a PKC activator and if the differences between the antiproliferative effect of mezerein and of its analogue daphnetoxin may be ascribed to differences on their potency or selectivity as PKC activators. Yeast samples expressing each of the mammalian PKC isoforms tested were incubated with daphnetoxin or mezerein. Growth inhibition caused by these drugs was assumed to be due to PKC activation since it did not occur when expression was not induced. Mezerein inhibited the growth of yeast expressing PKCα (IC50 = 1190 ± 237 nM; n = 20), PKCβI (IC50 = 908 ± 46 nM; n = 20), and PKCδ (IC50 = 141 ± 25 nM; n = 20) but not of yeast expressing PKCζ. Daphnetoxin also inhibited the growth of yeast expressing isoforms α, βI and δ, being more potent than mezerein on PKCα (IC50 = 536 ± 183 nM; n = 20; P < 0.05), as potent as mezerein on PKCβI (IC50 = 902 ± 129 nM; n = 20) and less potent than mezerein upon PKCδ (IC50 = 3370 ± 492 nM; n = 20; P < 0.05). These results show that daphnetoxin is a potent PKC activator but with a selectivity different from that of mezerein. It is suggested that the lack of antileukemic and antiproliferative effects of daphnetoxin may be due to its lower potency to activate PKCδ.